SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 5th, 2014 • Protalex Inc • Services-commercial physical & biological research • New York
In addition, we or the FDA and/or foreign regulatory agencies may suspend our clinical trials at any time if it appears that we are exposing participants to unacceptable health risks or if the FDA and/or foreign regulatory agencies find deficiencies in our IND and/or country specific regulatory submissions or in the conduct of these trials. Therefore, we cannot predict with any certainty the schedule for future clinical trials.
